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Abstract.  Transduction of signals initiating  motility by 
extracellular matrix  (ECM) molecules differed depend- 
ing on the type of matrix molecule and whether the 
ligand was in solution or bound to a  substratum.  Lam- 
inin,  fibronectin, and type IV collagen stimulated both 
chemotaxis and haptotaxis of the A2058 human mela- 
noma cell line.  Peak chemotactic responses were 
reached at 50-200 nM for laminin,  50-100 nM for 
fibronectin, and 200-370 nM for type IV collagen. 
Checkerboard analysis of each attractant  in solution 
demonstrated a predominantly directional  (chemotac- 
tic) response, with a minor chemokinetic component. 
The cells also migrated in a concentration-dependent 
manner  to insoluble step gradients of substratum- 
bound attractant  (haptotaxis).  The haptotactic re- 
sponses reached maximal  levels at coating concentra- 
tions of 20 nM for laminin  and type IV collagen, and 
from 30 to 45 nM for fibronectin.  Pretreatment of 
cells with the protein synthesis inhibitor,  cyclohex- 
imide (5 #g/ml),  resulted in a 5-30%  inhibition  of 
both chemotactic and haptotactic responses to each 
matrix protein,  indicating that de novo protein synthe- 
sis was not required for a  significant motility response. 
Pretreatment of cells with 50-500 #g/ml of synthetic 
peptides containing  the fibronectin cell-recognition se- 
quence GRGDS resulted in a concentration-dependent 
inhibition of fibronectin-mediated chemotaxis and hap- 
totaxis (70-80%  inhibition compared to control motil- 
ity); negative control peptide GRGES had only a mini- 
mal effect. Neither GRGDS nor GRGES significantly 
inhibited motility to laminin or type IV collagen. 
Therefore, these results support a  role for the RGD- 
directed integrin receptor in both types of motility re- 
sponse to fibronectin. 
After pretreatment  with pertussis toxin (PT), che- 
motactic responses to laminin,  fibronectin,  and type 
IV collagen were distinctly different. ChemotaXis to 
laminin  was intermediate in sensitivity; chemotaxis to 
fibronectin was completely insensitive;  and chemotaxis 
to type IV collagen was profoundly inhibited by PT. In 
marked contrast to the inhibition of chemotaxis, the 
haptotactic responses to all three ligands were 
unaffected by any of the tested concentrations of PT. 
High concentrations of cholera toxin (CT;  10 #g/ml) 
or the cAMP analogue,  8-Br-cAMP (0.5 mM), did not 
significantly affect chemotactic or haptotactic motility 
to any of the attractant proteins,  ruling out the in- 
yolvement of cAMP in the biochemical pathway initi- 
ating motility in these cells. The sensitivity of chemo- 
taxis induced by laminin and type IV collagen, but not 
fibronectin, to PT indicates the involvement of a PT- 
sensitive G protein in transduction  of the signals initi- 
ating motility to soluble laminin  and type IV collagen. 
The insensitivity of haptotaxis to PT indicates that for 
these two attractants,  chemotaxis and haptotaxis are 
induced by distinct transduction mechanisms. 
I 
NVASION and metastatic spread of malignant neoplasms 
are associated with active  locomotion of tumor cells. 
This locomotion occurs at the site of the primary growth 
(46), as well as during entrance and egress from blood ves- 
sels (44). Many factors derived from host tissues have been 
shown to stimulate motility of tumor ceils in vitro, including 
factors derived from resorbing bone (32),  from liver and 
lung (16), from the fifth component of human  complement 
(35), and certain growth factors (43).  In addition,  an auto- 
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crine motility factor (AMF) ~ produced by a human mela- 
noma cell line has been found to stimulate the intrinsic motil- 
ity of the same cells (25).  These factors are believed to 
influence  both the extent  and  the direction of tumor cell 
movement in vivo, facilitating penetration  of host tissue bar- 
riers and serving to "home" tumor cells to specific target or- 
gans. Components of the extracellular  matrix (ECM) includ- 
!. Abbreviations  used in this paper:  AMF, autocrine motility  factor; CT, 
cholera toxin; DPBS,  Dulbecco's  phosphate-buffered  saline;  ECM,  ex- 
tracellular matrix; 8-Br-cAMP,  8-bromoadenosine 3':5' cyclic monophos- 
phate; G proteins, guanine nucleotide-binding proteins; HPF, high power 
field;  IGF-I,  insulin-like growth factor I; PT, pertussis toxin. 
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and serum spreading factor (vitronectin), as well as their 
proteolytic digestion products, also stimulate the in vitro mi- 
gration of a variety of normal cells and tumor cells (1,  14, 
26-29, 39, 47, 54). The intact ECM molecules are distinct 
from the other motility-stimulating factors in that they are 
present in vivo as insolubilized structures mediating cell at- 
tachment, although soluble forms of fibronectin and vitro- 
nectin are also present in plasma. Interactions of tumor cells 
with the ECM at multiple stages in the metastatic cascade 
(24) could considerably influence invasion and metastasis by 
contributing to the movement of tumor cells through vascu- 
lar basement membrane and interstitial stroma. The highly 
aggressive human melanoma cell line A2058 has been found 
to migrate in response to several diverse attractant molecules 
(25,  43, 47,  54). We used this cell line to study the nature 
of  the motility responses to laminin, fibronectin, and type IV 
collagen, three ECM proteins encountered by tumor cells 
during metastatic spread. 
The term "chemotaxis" has been used to describe tumor 
cell motility and is presumed to refer to directed migration 
towards a  soluble attractant,  although this has not always 
been shown directly. Alternatively, tumor cell motility to- 
ward  substratum-bound,  insolubilized  laminin  and  fibro- 
nectin has been termed "haptotaxis" (26,  27). However, the 
distinction  between  chemotaxis  and  haptotaxis  to  ECM 
components has not always been made clear, and uncertainty 
exists as to whether there are fundamental differences be- 
tween the two processes.  Recently, Taraboletti et al.  (47) 
established that separate domains on the NH2- and COOH- 
terminal  regions of the thrombospondin molecule are  re- 
sponsible for chemotaxis and haptotaxis, respectively, and 
that the two processes could be differentially inhibited by an- 
tibodies to the relevant sites. This suggests that these func- 
tionally distinct domains stimulate motility through separate 
receptors on the cell surface. The potential importance of a 
chemotactic response to ECM components is apparent when 
considering that during the process of tumor invasion and 
metastasis, proteolytic degradation results in solubilization 
of ECM components (23).  As a  result,  tumor ceils could 
conceivably detect and respond to the soluble fragments as 
well as to the insoluble intact matrix molecules. Therefore, 
chemotaxis and haptotaxis to ECM components could rep- 
resent two separate and distinguishable means by which tu- 
mor  cells  penetrate basement  membranes  and  interstitial 
stroma. 
Tumor cell migration is believed to result from the interac- 
tion of the attractant molecule with its specific receptor, as 
is the case for leukocytes. The signal transduction pathways 
that initiate tumor cell migration are among the least under- 
stood aspects of invasion and metastasis. The migratory re- 
sponse of the human melanoma cell line A2058 to its AMF 
is known to be extremely sensitive to pertussis toxin (PT) 
pretreatment,  which  in  other  cells  is  known  to  ADP- 
ribosylate and inactivate certain receptor coupled guanine 
nucleotide-binding proteins (G proteins) (42). However, mi- 
gration of the same cell line to insulin-like growth factor I 
(IGF-I) is completely insensitive to PT pretreatment, distin- 
guishing  the  immediate  postreceptor  signal  transduction 
events in the chemotactic responses to the two attractants 
(43). In this study, we assessed the migratory responses of 
the A2058 cell line to laminin, fibronectin, and type IV col- 
lagen presented to the cells both as soluble (cbemotaxis) and 
as insoluble, substratum-bound attractants (haptotaxis). To 
determine if a  toxin-sensitive G  protein is involved in the 
transduction of these motility signals, we also tested the sen- 
sitivity of each response to PT pretreatment of the cells. To 
assess a possible role of RGD-directed integrin receptors in 
these ECM-induced motile responses,  we pretreated cells 
with soluble RGD-containing peptides. Finally, to examine 
the possibility that the cells were secreting a substance that 
could affect cell motility, we determined the effect of pre- 
treating the cells with the protein synthesis inhibitor, cyclo- 
heximide. 
Materials and Methods 
Laminin was purified from the Engelbreth-Holm-Swarm  tumor as described 
(50). The isolated laminin (Mr 900,000) was checked for purity by exami- 
nation on 5% SDS-PAGE run under reducing conditions. Fibronectin (Mr 
440,000) and type IV collagen (Mr 540,000)  were purchased from Collabo- 
rative Researeh, Inc. (Bedford, MA). Purity was verified by PAGE and ro- 
tary shadowing EM (performed by Inger Marguiies, Laboratory of Pathol- 
ogy, National Cancer Institute, National Institutes of Health). The type IV 
collagen contained both the 7S amino-terminal domain and the globular 
NC1 carboxyl-terminal domain. PT and cholera toxin (CT) were from List 
Biological Laboratories, Inc. (Campbell, CA). The Nuclepore membranes 
(polyvinyl-pyrrolidone-fre¢)  and the 48-weU chemotaxis chamber were pur- 
chased from Neuro Probe, Inc.  (Cabin John,  MD).  Cycloheximide and 
8-bromo-adenosine 3':5'-cyclic monophosphate (8-Br-cAMP) were from 
Sigma Chemical Co. (St. Louis, MO). 
Cell Culture 
The human melanoma cell line, A2058 (5D, was maintained in culture in 
DME  supplemented  with  10%  FBS.  Medium  and  serum  were  from 
Biofluids, Inc. (Gaithersburg, MD). 
Cell Motility Assays 
Cells in logarithmic phase of growth were detached by brief exposure to 
0.05%  trypsin/0.02% EDTA and allowed to regenerate for 1 h in serum- 
containing medium. The cells were then centrifuged at 800 g for 5 rain and 
resuspended at 2  x  106/ml in serum-free DME containing 0.1% BSA. In 
experiments with PT and CT, cells were preincubated with the toxins for 
an additional 2 h at room temperature. For PT, chemotaxis to AMF was 
run as a positive control to test the toxin efficacy. In experiments with syn- 
thetic  peptides, cycloheximide and 8-Br-cAMP, cells were preincubated 
with each agent for 1 h. For each set of experiments, untreated control cells 
were preincubated under the same conditions as the treated cells. Motility 
assays were carried out in the presence of the toxins, peptides, and pharma- 
cological agents. 
Determination ofHaptotaxis. Haptotaxis was assayed in triplicate using 
modified Boyden chambers, with 8-#m pore size polycarbonate Nuclepore 
filters (13-mm-diam). Filters were floated overnight at 37°C on a solution 
of laminin, fibronectin, or type IV collagen diluted to the indicated concen- 
tration in DPBS, similar to the method described by McCarthy and Purcht 
(27). Negative control filters were floated on Dulbecco's PBS (DPBS) alone. 
Chambers were assembled with serum-free DME containing 0.1% BSA in 
the lower compartment. All filters were washed five times with DPBS, 
dried, and placed in the chamber so that the side of the filter with the higher 
concentration of protein faced the lower compartment. After addition of 4 
×  105 cells to the upper compartment, chambers were incubated in a hu- 
midified atmosphere at 37°C for 5 h. At the end of the assay, filters were 
removed, fixed and stained with Diff-Quik (Baxter Scientific, McGaw Park, 
IL), and then mounted on glass slides. Cells that had migrated were quanti- 
tated by light microscopy under high power field (HPF) (500x).  For each 
replicate, the number of  cells in five randomly chosen HPFs was determined 
and the counts were averaged. 
Determination of Chemotaxis. Chemotaxis was assayed in triplicate 
using 48-well microchemotaxis chambers as described previously (13) with 
8-#m pore size polycarbonate Nuclepore filters. Filters were precoated on 
both sides to enhance cell adherence by soaking overnight in solutions of 
gelatin (I00 #g/ml in 0.02 M acetic acid for chemotaxis to laminin and in 
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acid for chemotaxis to fibronectin), or fibroneetin (10 t~g/ml in cyclohexyl- 
aminopmpane sulfonic acid [CAPS] buffer for chemotaxis to type IV colla-  so 
gen). ECM components to be tested as chemoattractants were diluted to the  ~- 
=  sol  indicated concentrations into serum-free DME containing  0.1% BSA and 
added to the lower wells, while the upper wells received 1.1  x  l0  s cells.  ~  40 
The chambers were incubated at 37"C for 4 h. Filters were then processed 
and migration  quantitated as for haptotaxis. Untreated cells, as well as cells  20 
from every treatment group, were tesled for their unstimulated random mo- 
tility in response to DME with 0.1% BSA in the lower wells.  0 
Stimulated motility represents the total motile response minus the un- 
stimulated random motility. In haptotaxis, random motility did not exceed 
two to four cells per HPE Average  unstimulated random motility  in chemo- 
taxis was 10 cells per HPF with laminin as attractant, 22 cells per HPF with 
fibronectin, and 2-10 cells per HPF with type IV collagen. 
Preparation of Synthetic Peptides 
The two peptides, GRGDS and GRGES, were synthesized using a peptide 
synthesizer (model 9600; Biosearch, San Rafael, CA). The Biosearch pre- 
programmed t-Boc Merrifield solid-phase protocol was used in these prepa- 
rations. 
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Figure 2. Concentration curves 
of A2058 cbemotactic response 
to ECM components. Cell mo- 
tility  was assessed  in 48-well 
microchemotaxis chambers. 
Increasing  concentrations  of 
laminin (zx), type IV collagen 
(t3), and fibronectin  (O) were 
diluted in DME supplemented 
with 0.1% BSA and added to 
the lower wells.  Polycarbon- 
ate filters were precoated on both sides with a noninteracting  adhe- 
sive protein (see Materials  and Methods).  After addition  of 1.1  x 
IO  s cells to the upper compartments, chambers were incubated  at 
37°C for 4 h. Data represent  the mean of triplicate  determinations 
for a single  representative  experiment of migrated cells per HPF 
(~  +  SEM).  All experiments  were  repeated  five to seven times. 
Nonspecific  random migration was subtracted  out for each data 
point. 
Results 
Haptotactic Migration  ofA2058 Cells 
to ECM Components 
A2058 cells migrated over a step-density gradient of substra- 
tum-bound laminin, type IV collagen, and fibronectin in the 
absence of soluble attractant.  With each ECM protein,  in- 
creasing the gradient resulted in a higher level of migration 
until a plateau was reached, which could result from satura- 
tion of the filters at the higher coating concentrations.  Fig. 
1  shows  representative  concentration-response  curves  of 
stimulated motility with each attractant protein. The hapto- 
tactic responses to laminin and to type IV collagen reached 
a peak when concentrations of •  20 nM were used to coat 
the filters.  Increasing coating concentrations to 100 nM did 
not  result  in  significant  change  in  migration  levels.  With 
fibronectin, the peak response occurred at the slightly higher 
coating concentration of 30-45 nM and, as with laminin and 
type IV collagen, remained at this level when up to fivefold 
of that coating concentration was used.  With each protein, 
the maximal response was >50-fold above unstimulated ran- 
dom motility. In a separate set of controls, migration over a 
gradient of an unrelated, nonmatrix protein was assessed by 
coating filters on the lower side with BSA exactly as done 
100 
8O 
~  4o 
~J 
29 
0 
I0  100  1000 
COATING CONC (nM) 
Figure 1. Concentration curves 
of A2058 haptotactic  response 
to ECM components. Cell mo- 
tility was assessed in modified 
Boyden chambers. Polycarbon- 
ate filters were precoated with 
a  step  gradient of increasing 
concentrations  of laminin (A), 
type IV collagen (m), or fibro- 
nectin (o). Filters were placed 
in the chambers with the high- 
er protein side facing the lower 
well.  After addition  of 4  ×  10  ~ cells  to the upper compartment, 
chambers were incubated at 37°C for 5 h. Data represent the mean 
of triplicate determinations  for a single representative experiment of 
migrated cells per HPF (~- +  SEM). All experiments were repeated 
five to seven times.  Nonspecific  random migration  was subtracted 
out for each data point. 
for laminin, fibronectin, and type IV collagen. Over a coat- 
ing concentration range of 1.5-735  nM,  BSA did not sig- 
nificantly stimulate haptotactic response (not shown). 
Chemotactic Migration ofA2058 Cells 
to ECM Components 
A2058  cells  also  migrated  in  a  concentration-dependent 
manner to soluble laminin,  fibronectin,  and type IV colla- 
gen. In Fig. 2, representative concentration-response curves 
of stimulated motility are shown. Concentrations of laminin 
>1 nM stimulated migration over background levels, with a 
peak in response occurring in the range of 50 to 200 nM (six- 
fold above unstimulated motility). Higher concentrations of 
fibronectin (20-50 nM)  were required  to stimulate  migra- 
tion,  but the maximal  response  (at 50-100 nM),  although 
still significant, was only 2- to 4.5-fold increased above un- 
stimulated motility. Migration to both laminin and fibronec- 
tin declined at concentrations higher than those which elic- 
ited a maximal response, resulting in bimodal curves. Type 
IV collagen elicited a peak response at 200-370 nM, which 
was 50-fold above unstimulated  motility,  and substantially 
higher than the peak responses to laminin and fibronectin. 
Over the concentration range tested, a decline in motility re- 
sponse to type IV collagen either was not observed or was 
very slight. 
Checkerboard analysis (Figs. 3, 4, and 5) was performed 
with each protein in solution to assess the random (chemoki- 
netic) or directed (chemotactic) nature of the tumor cell mi- 
gratory response.  Chambers were assembled with different 
ratios  of the  attractant  above  and  below  the  filter.  The 
squares  below the diagonal  reflect  responses  to a  positive 
gradient, whereas those above the diagonal reflect responses 
to a negative gradient. The values along the diagonal indicate 
random motility to uniform concentrations of soluble attrac- 
tant added to both sides of the chamber. Checkerboard anal- 
ysis indicated that laminin stimulated both random and di- 
rected  motility  (Fig.  3),  although  directed  motility  was 
stimulated to a greater extent (maximum of sixfold increase 
over background compared with a fourfold increase for ran- 
dom migration). Type IV collagen also stimulated both che- 
motaxis  and chemokinesis  (Fig.  4),  with  the  chemotactic 
response predominating (values below the diagonal). Fibro- 
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Figure 3. Checkerboard analysis of the chemotactic activity of lam- 
inin (LAM). Varying concentrations of soluble laminin were added 
to the upper chamber with the cells or to the lower chamber, as indi- 
cated. Motility response is expressed as the mean of triplicate de- 
terminations of migrated cells per HPF (x  ___ SEM). 
nectin (Fig. 5) stimulated directed motility with only a minor 
chemokinetic  effect  at  the  lower  uniform  concentrations 
(along the diagonal). No significant migration to a negative 
gradient of attractant was observed with any of the proteins. 
To confirm that the attractants were remaining in solution 
under conditions of the assay, two sets of controls were car- 
ried out. In the first set, laminin was iodinated to a specific 
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Figure 4. Checkerboard analysis of the chemotactic activity of type 
IV collagen. Varying concentrations of soluble type IV collagen 
were added to the upper chamber with the cells or to the lower 
chamber, as indicated.  Motility response is expressed as the mean 
of triplicate determinations  of migrated cells per HPF (x +  SEM). 
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Figure 5.  Checkerboard analysis  of the  chemotactic activity  of 
fibronectin  (FN).  Varying concentrations  of soluble  fibronectin 
were added to the upper chamber with the cells or to the lower 
chamber, as indicated. Motility response is expressed as the mean 
of triplicate determinations of migrated cells per HPF (% +  SEM). 
activity of 4/~Ci/#g with immobilized lactoperoxidase (En- 
zymobeads; Bio-Rad Laboratories,  Richmond,  CA).  Iodi- 
nated laminin (25  x  10  ~ cpm)  was mixed with unlabeled 
laminin to a final concentration of 100/~g/ml and added to 
the lower well of the chamber. The chamber was assembled 
with a gelatin-coated filter and incubated as for chemotaxis, 
with BSA-DME  in the upper well.  At the end of the incu- 
bation,  the radioactivity  associated  with  the  liquid  phase 
(both upper and lower wells) and the filter (after washing) 
was quantitated,  and 70-80%  of the radioactivity initially 
added to the lower well was in the liquid phase. Only 5-7% 
was associated with the filter, and the remaining 10-13%  of 
radioactivity was left behind on the chamber. In the second 
set of controls, unlabeled laminin and fibronectin were di- 
luted into BSA-DME to concentrations stimulating chemo- 
taxis, and aliquots of each were placed in the lower wells of 
separate chambers which were then overlaid with the appro- 
priate  filter.  Chambers were incubated as for chemotaxis, 
with buffer in the upper wells.  At the end, the solutions in 
the lower wells were diluted  1:2  in sample buffer (0.01  M 
Tris-HC1, 2%  SDS,  10%  glycerol, 7%/~-mercaptoethanol, 
0.001%  bromphenol blue, pH 6.8) and electrophoresed under 
reducing conditions in a 6% SDS-polyacrylamide gel. Equal 
volumes of the laminin and fibronectin solutions that had not 
been incubated were also electrophoresed for comparison. 
After Coomassie staining, the intensity of protein stain was 
roughly equivalent in the paired samples before and after in- 
cubation,  demonstrating  that  the  laminin  and  fibronectin 
which had been incubated in the chambers had remained in 
solution (not shown). 
Effect of PT on Motility to ECM Components 
PT inactivates certain G proteins by ADP-ribosylation (11), 
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involvement in a cellular response. The motility response of 
the A2058  melanoma cell line to its AMF has previously 
been shown to be sensitive to inhibition by PT, indicating di- 
rect participation of a  G  protein in the signal transduction 
pathway employed by AMF (42). In contrast, motility of the 
same cell line in response to IGF-I is completely insensitive 
to the effects of PT, implicating the involvement of a different 
signal transduction pathway (43). 
In this study, we first tested a wide range of PT concentra- 
tions to determine the PT sensitivity of the chemotactic or 
haptotactic motility responses to the matrix proteins lami- 
nin, fibronectin, and type IV collagen, using optimally stim- 
ulating concentrations of each protein. Fig. 6 A illustrates the 
effects of PT pretreatment on laminin-stimulated haptotaxis 
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Figure 6. The effect of PT on motility to ECM components. Cells 
were preincubated  with varying concentrations  of PT for 2 h at 
25°C before assays. Cell chemotactic (open symbols) and haptotac- 
tic (closed  symbols) responses were assessed for each ECM compo- 
nent in parallel experiments on the same day. (A) Laminin-induced 
motility  responses.  The haptotactic  response  was assessed  to a 
filter-coating concentration  of 20 nM. Chemotaxis was measured 
in response  to  110 nM  soluble  laminin.  (B) Type IV collagen- 
induced motility responses. The haptotactic response was assessed 
to a filter-coating concentration  of 20 nM. Chemotaxis  was mea- 
sured  in  response  to  280  nM  soluble  type  IV  collagen.  (C) 
Fibronectin-induced  motility responses.  The haptotactic  response 
was assessed to a filter-coating concentration  of 45 nM. Chemo- 
taxis was measured in response to 110 nM soluble fibronectin. Re- 
suits are the mean of triplicate determinations for a single represen- 
tative experiment and are expressed as percent of control stimulated 
migration in the absence of PT (~ +  SEM). All experiments were 
repeated three to four times. 
Table L Effect of CT on ECM-induced Motility 
Chemotaxis  Haptotaxis 
% of control  Coating  % of control 
Anractant  Concentration*  motility¢  concentration*  motility~ 
nM  %  nM  % 
Laminin  110  92.5  (10,5)  20  102  (1.6) 
Collagen IV  280  85.8 (4.3)  20  101  (5.3) 
Fibronectin  60  96.1  (10.0)  45  97.8 (3.8) 
* For each attractant, the concentrations that maximally stimulated motility in 
both types of assay were chosen, 
~t Cells were pretreated  with  10/~g/ml CT in 0.1%  BSA or 0. 1% BSA alone 
(control) for 2 h before the assay.  Results for CT-treated cells are expressed 
as percent of control  motility [~  +  (SEM)I. 
and chemotaxis. The chemotactic response to laminin (110 
nM) was moderately sensitive to PT, with 0.01-1.0 #g/ml of 
PT causing a maximal inhibition of ~50% of the control re- 
sponse.  In  contrast,  the  haptotactic  response  to  laminin 
(coating concentration of 20 nM) was not inhibited by any 
concentration of PT tested. Haptotactic and chemotactic re- 
sponses to type IV collagen were also differentially sensitive 
to inhibition by PT pretreatment of the cells (Fig. 6 B). Type 
IV collagen  (280  nM)  stimulated  a  chemotactic response 
which was profoundly inhibited to <30% of control motility 
with  10 ng/ml of PT, whereas higher concentrations of the 
toxin virtually abolished the chemotactic response. In marked 
contrast,  haptotaxis to the same attractant protein (20 nM 
coating concentration) was completely insensitive to inhibi- 
tion by PT. For laminin and type IV collagen, the PT sensi- 
tivity did not appear to depend on the nature of the coating 
material because the inhibition by PT was unchanged when 
either gelatin or fibronectin was used to coat the membranes 
(results  not shown).  In addition,  cellular  adhesion  to  the 
gelatin- and fibronectin-coated filters used for chemotaxis to 
laminin and type IV collagen, respectively, was unaffected 
by pretreatment with PT, as judged visually. Similarly, pre- 
treatment with PT did not affect adhesion to the coated filters 
used for haptotaxis. Cell viability, assessed by trypan blue 
exclusion, was unimpaired at any concentration of PT. 
Results with fibronectin (Fig. 6 C) differed from those of 
laminin and  type IV collagen.  Fibronectin  (110  nM)  was 
used as chemoattractant, and a coating concentration of 45 
nM was used to precoat filters for haptotaxis. Neither che- 
motaxis nor haptotaxis to fibronectin was sensitive to the in- 
hibitory effect of PT, suggesting that both types of motility 
response to this attractant are activated through second mes- 
senger pathways which  do  not  involve PT-sensitive trans- 
ducer G proteins. As found for laminin- and type IV colla- 
gen-mediated  chemotaxis,  the  nature  of  the  membrane 
coating (laminin or type IV collagen coated) did not alter the 
effect of PT upon fibronectin-mediated chemotaxis. 
A second set of experiments was performed using subopti- 
mal concentrations of attractant to see if PT could exert an 
effect which was obscured at maximal stimulatory concen- 
trations for each matrix protein.  In these experiments, the 
PT concentration was kept constant (0.5 #g/ml) and the at- 
tractant concentrations were varied. For haptotaxis, because 
of the near "all or nothing" nature of the response, generally 
only one or two suboptimal concentrations could be attained 
in any assay. However, PT had no significant effect on any 
of the three ECM components at any coating concentration 
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protein was tested for PT sensitivity over a full range of che- 
motactic concentrations.  PT had no effect on fibronectin- 
stimulated  chemotaxis.  In contrast,  type IV collagen and 
laminin were sensitive to the toxin over their full range of 
concentrations with type IV collagen profoundly inhibited 
and laminin partially inhibited throughout the assay (results 
not shown). 
Effect of CT and a cAMP Analogue on 
ECM-induced Motility 
PT is known to ADP-ribosylate and inactivate several G pro- 
teins  including  G~,  the  inhibitory  G  protein  for adenylate 
cyclase (10, 11, 31). If the PT effect on chemotaxis were me- 
diated by G~, treating cells with toxin would abolish both 
basal- and receptor-mediated inhibition of adenylate cyclase 
activity, resulting in a net accumulation of cAMP (19,  31). 
To determine whether cAMP could be contributing to the de- 
creased chemotactic motility of PT-treated cells to laminin 
and type IV collagen, we tested the effect of another agent 
known to have a stimulatory effect on adenylate cyclase, CT. 
Cells were pretreated with CT at a concentration of 10 #g/ml 
and tested for their motility response to maximally stimulat- 
ing concentrations of attractant proteins (Table I). It is evi- 
dent  that  CT  at  this  concentration  does  not  significantly 
affect chemotactic or haptotactic motility to any of the at- 
tractants (all treatment groups still demonstrated >85 % of 
control  motility).  Likewise,  to  test  directly  the  effect of 
cAMP on motility to the matrix proteins,  cells were pre- 
treated  with the  cAMP  analogue,  8-Br-cAMP,  which  has 
been shown to cross cell membranes (8, 22). Untreated cells 
were tested  simultaneously as a  positive control  for each 
ECM protein. The results (Table II) reveal no significant in- 
hibition or stimulation of any of the chemotactic or haptotac- 
tic responses (91-104% of the control response). In addition, 
unstimulated  random  motility  was  also  unaffected  by the 
drug (results not shown). These data indicate that laminin, 
fibronectin, and type IV collagen stimulate motility in these 
cells through second messenger pathways which  are inde- 
pendent of the adenylate cyclase system. 
Effect of  Peptide GRGDS on Chemotaxis and 
Haptotaxis to ECM Proteins 
Many adhesive proteins in the ECM and in the blood contain 
the tripeptide arginine-glycine-aspartic acid (RGD) as their 
Table II. Effect of 8-Br-cAMP on ECM-induced Motility 
Chemotaxis  Haptotaxis 
% of control  Coating  % of control 
Attractant  Concentration*  motility~  t  concentration*  motility:~ 
nM  %  nM  % 
Laminin  100  103  (10.3)  20  95.9 (5.1) 
Collagen IV  250  104  (8.0)  20  91.5  (2.8) 
Fibronectin  100  92.6 (15.4)  45  104  (7.7) 
* For each attractant, the concentrations that maximally stimulated motility in 
both types of assay were chosen. 
~: Cells were pretreated with 0.5 mM 8-Br-cAMP in 0.1%  BSA or 0. 1% BSA 
alone (control) for 1 h before the assay.  Results for 8-Br-cAMP-treated cells 
are expressed as percent of control  motility I'g +  (SEM)]. 
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Figure 7. Effect of peptides GRGDS and GRGES on fibronectin- 
stimulated motility. Cells were preincubated with varying concen- 
trations of GRGDS (circles) or ORGES (triangles) for I h at 25°C 
before assays. (A) The haptotactic  responses  were assessed to a 
filter coating concentration  of 45 nM. (B) Chemotaxis was mea- 
sured in response to 110 nM soluble fibronectin.  Results are the 
mean of  triplicate determinations for a single representative experi- 
ment and are expressed as percent of control stimulated migration 
in the absence of peptides (g  +  SEM).  These experiments were 
repeated three to six times. 
cell recognition site, including fibronectin, vitronectin, col- 
lagens, thrombospondin, and others. These RGD sequences 
are recognized by members of a  large,  structurally related 
group of cell surface receptors, the integrins, which mediate 
cell-matrix or cell-cell interactions (38). 
Soluble synthetic peptides containing the RGD sequence 
can inhibit the attachment of cells to a surface coated with 
fibronectin (33). To determine if the RGD site was necessary 
to generate a motility response to fibronectin, we pretreated 
melanoma cells with the peptide GRGDS, negative control 
peptide GRGES, or media alone. Motility of cells to a maxi- 
mally stimulating concentration of fibronectin was then as- 
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shows the effect of the peptides on haptotaxis to fibronectin. 
Pretreatment with increasing concentrations of GRGDS re- 
sulted in progressively greater inhibition of the haptotactic 
response. At the highest concentration of peptide tested (500 
#g/ml),  haptotaxis was reduced to 20%  of the control re- 
sponse. This inhibition was accompanied by reduced adher- 
enc~ of cells to the fibronectin-coated filters, as judged visu- 
ally by the absence of a cell pellet on the top of the filters. 
In contrast, the presence of negative control peptide GRGES 
affected haptotaxis only slightly at the highest concentration 
tested (~80% of control response). This could be attributed 
to a nonspecific effect of the peptide on the cells. Similarly, 
pretreatment of cells with GRGDS inhibited chemotaxis to 
fibronectin in a concentration-dependent manner (Fig. 7 B). 
Maximal inhibition (to 30% of control motility) was achieved 
with 200 #g/ml of the peptide. No inhibition of chemotaxis 
was observed when cells were treated with negative control 
peptide  GRGES.  Adhesion  of cells  to  type IV  collagen- 
coated filters used for fibronectin chemotaxis appeared to be 
reduced by ~20% at 500/~g/ml of GRGDS or GRGES, but 
not by lower concentrations of the two peptides.  Pretreat- 
ment with the peptides did not significantly impair cellular 
viability at any of the concentrations tested, as judged by try- 
pan blue exclusion. These results indicate .that both chemo- 
taxis and haptotaxis to fibronectin require cellular interac- 
tion with the RGD site in the fibronectin molecule. 
Although RGD sequences exist in laminin and type IV col- 
lagen,  they do not appear to represent major cell binding 
sites. We assessed the effect of the RGD peptides on motility 
of the cells to maximally stimulating concentrations of lami- 
nin  and  type  IV  collagen.  For  comparison,  results  with 
fibronectin are also included in Fig.  8 A, which illustrates 
the effect of the peptides on haptotaxis to the ECM proteins. 
Although GRGDS dramatically inhibited haptotaxis to fi- 
bronectin  in  a  concentration-dependent manner,  it had  a 
minimal effect on haptotaxis to type IV collagen and lami- 
nin. At high concentrations (500 #g/ml), both peptides caused 
a slight reduction in haptotaxis to type IV collagen. Hapto- 
taxis to laminin was not affected significantly by either pep- 
tide. A similar pattern of results was seen with chemotaxis 
to the ECM proteins (Fig. 8 B). Again, the GRGDS peptide 
strongly inhibited chemotaxis to fibronectin while the nega- 
tive control peptide had no effect. These same peptides did 
not inhibit chemotaxis to type IV collagen at all though adhe- 
sion to the fibronectin-coated membranes appeared to be de- 
creased.  When gelatin-coated filters were used  instead  of 
fibronectin-coated filters, the chemotactic response to type 
IV  collagen remained  insensitive to the peptide GRGDS. 
Chemotaxis to  laminin  was  slightly  inhibited  when  cells 
were treated with 500 #g/ml of either peptide, but not with 
200 #g/ml. In conclusion, haptotaxis and chemotaxis to type 
IV collagen and laminin are not mediated through cellular 
binding to RGD sequences in these proteins. When a slight 
inhibitory effect of the peptides was observed, it was seen for 
both  GRGDS  and  negative  control  GRGES,  indicating  a 
nonspecific inhibition. 
Effect of Cycloheximide on Chemotaxis and 
Haptotaxis to ECM Components 
To determine whether the A2058  ceils were synthesizing 
Figure 8. Effect  of peptides GRGDS and GRGES on laminin- and 
type IV collagen-stimulated motility. Cells were preincubated with 
GRGDS at 200 #g/ml  (stippled) or 500 #g/ml  (open), or with 
GRGES at 200 #g/ml (diagonal  hatching) or 500 #g/ml (horizontal 
hatching) for 1 h at 25°C before assays. Cells preincubated with 
DME supplemented with 0.1% BSA were tested concurrently as 
controls (solid). (A) Haptotactic responses were assessed to filter- 
coating concentrations of 20 nM for laminin (LAM) and type IV 
collagen (COLL IV) or 45 nM for fibronectin (FN). (B) Chemo- 
taxis was measured in response to 110 nM soluble laminin, 280 nM 
soluble type IV collagen, or 110 nM soluble fibronectin. Data rep- 
resent the mean of triplicate determinations for a single representa- 
tive experiment of migrated cells per HPF (X + SEM). Nonspecific 
random migration was subtracted out for each data point. These ex- 
periments were repeated three times. 
proteins which affected the motility responses to the ECM 
components over the course of a 4-5-h assay, we performed 
assays in the presence of an inhibitor of protein synthesis. 
Cycloheximide (5 #g/ml) has been shown to inhibit incorpo- 
ration of [35S]methionine into A2058 cells (24). When cells 
were pretreated with this pharmacologic agent, both hapto- 
tactic and chemotactic motility responses were slightly in- 
hibited (5-30%) for each ECM protein (Fig. 9). This inhibi- 
tion appeared to be nonspecific because both haptotactic and 
chemotactic responses were affected, and each matrix pro- 
tein was inhibited to a similar degree. However, cyclohex- 
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nectin-induced  chemotaxis and haptotaxis in approximately 
equal  proportions  (5-24%  vs.  14-30%,  respectively).  To 
find out whether the effect of GRGDS on fibronectin-induced 
chemotaxis and haptotaxis could be abolished by inhibition 
of protein  synthesis,  we performed a  series of experiments 
in  which  the cells  were pretreated  with  the peptides  alone 
(GRGDS and GRGES),  with cycloheximide alone,  or with 
both cycloheximide plus the peptides.  Untreated  cells were 
tested simultaneously as positive controls.  The results (Fig. 
10) show that GRGDS inhibited both chemotaxis and hapto- 
taxis to fibronectin  (60  and  34%  inhibition,  respectively). 
Cycloheximide  also inhibited  both  the  chemotactic  (24%) 
and haptotactic  (14%) responses.  When cycloheximide was 
added to GRGDS, the result appeared to be an additive  in- 
hibitory effect (80%  inhibition  compared with control cells 
for chemotaxis,  68 %  for haptotaxis).  In contrast,  GRGES 
plus cycloheximide was equivalent to cycloheximide alone. 
When similar experiments were performed using laminin as 
the chemotactic or haptotactic agent, GRGDS plus cyclohex- 
imide was equivalent to cycloheximide alone without any ad- 
ditive  inhibition  (results  not  shown).  These  experiments 
were also repeated using type IV collagen as the chemotactic 
or haptotactic agent. With type IV collagen, there appeared 
to be a  slight  increase  in  the  inhibitory  effect of cyclohex- 
imide plus either  GRGDS  or GRGES  (results  not shown). 
Therefore, the apparent increase in the inhibitory effect was 
nonspecific. 
Discussion 
Cells interact with the ECM through specific cell surface re- 
0 
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Figure 9. Effect of cycloheximide on motility to ECM components. 
A2058 cells were pretreated for I h at room temperature with cyclo- 
heximide at 5 ttg/ml (diagonal hatching). Identical cells, preincu- 
bated only in DME supplemented with 0.1% BSA, were tested con- 
currently  as  controls  (solid).  (A)  Haptotactic  responses  were 
assessed  to  filter  coating  concentrations  of 20  nM  for  laminin 
(LAM) and type IV collagen (COLLIV) or45 nM fibronectin (FN). 
(B) Chemotaxis was measured in response to 100 nM soluble lami- 
nin, 250 nM soluble type IV collagen, or 70 nM soluble fibronec- 
tin. Data represent the mean of triplicate determinations for a single 
representative experiment of migrated cells per HPF (x +  SEM). 
Nonspecific random migration was subtracted out for each data 
point.  These experiments were repeated two times. 
imide failed to abolish any of the motility responses. There- 
fore,  the  cells  do  not  appear  to  require  de  novo  protein 
synthesis to mount a  significant chemotactic or haptotactic 
response to the tested matrix proteins. In addition,  we noted 
that cycloheximide greatly decreased adherence (50-70 %, as 
judged visually) to all the chemotactic membranes (coated 
with type IV collagen, fibronectin, and gelatin). Because the 
motility  response  was  still  significant,  the  cells  appear  to 
need only minimal adherence in order to produce a chemo- 
tactic  response. 
Like the peptide GRGDS, cycloheximide inhibited  fibro- 
Figure 10.  Effect of cycloheximide added to the peptides GRGDS 
and GRGES on fibronectin-stimulated motility.  A2058  cells were 
pretreated for 1 h at room temperature with GRGDS at 200 ttg/ml 
(diagonal hatching), GRGES at 200 ~g/ml (gray), cycloheximide 
at 5 #g/ml (open), cycloheximide at 5 ttg/ml plus GRGDS at 200 
/~g/ml (stippled), or cycloheximide at 5/xg/ml plus GRGES at 200 
#g/ml  (horizontal  bars). Identical  cells,  preincubated  only  in 
DME supplemented with 0.1%  BSA, were tested concurrently as 
controls (solid). The haptotactic response (HPTX) was assessed to 
a filter coating concentration of 45 nM fibronectin. The chemotac- 
tic response (C/X) was to 70 nM soluble fibronectin. Data repre- 
sent the mean of triplicate determinations for a single representative 
experiment of migrated cells per HPF (X  +  SEM).  Nonspecific 
random migration was subtracted out for each data point. These ex- 
periments were repeated two to three times. 
The Journal of Cell Biology, Volume 110, 1990  1434 ceptors. With normal cells, this interaction results in adher- 
ence and differentiation (6, 34, 53, 55); migration is stimu- 
lated only under specialized conditions such as development 
(49), wound healing and repair (17),  and inflammation (2, 
48). The migration of tumor cells in response to ECM pro- 
teins also is likely to result from receptor-mediated activa- 
tion. We tested the ECM components laminin, fibronectin, 
and type IV collagen and found that all stimulated both the 
chemotactic and haptotactic motility of the A2058 human 
melanoma cell line, depending on the conditions of the assay. 
Presentation of increasing concentration gradients of the sol- 
uble attractant proteins fibronectin,  laminin,  and type IV 
collagen resulted in a progressive increase in migration until 
a peak response was reached with bimodal concentration- 
response curves for laminin and fibronectin. To ensure that 
a pure chemotactic response was being tested, two modifica- 
tions of the assay procedure of McCarthy and Furcht (27) 
were carried out to keep the attractant proteins in solution. 
First, we precoated the filters on both sides with an adhesive 
protein (one that is thought not to bind strongly to the attrac- 
tant) distinct from the attractant protein. Second,  1 mg/ml 
BSA was added to the medium in which the attractant was 
diluted, so that an excess of carrier protein would coat any 
protein-binding sites on the chamber and on the filter sur- 
face.  Checkerboard analysis of each attractant  in solution 
demonstrated a predominantly directional (chemotactic) re- 
sponse, with a minor chemokinetic component. The mela- 
noma cells also migrated in a concentration-dependent man- 
ner to increasing step-density gradients of the insolubilized, 
substratum-bound attractants. The sensitivity of  chemotactic 
and haptotactic migration to inhibition by PT was assessed 
for each ECM protein. The chemotactic responses to lami- 
nin, fibronectin, and type IV collagen were distinctly differ- 
ent in the degree of inhibition caused by PT. Chemotaxis to 
type IV collagen was completely inhibited by PT, chemo- 
taxis to laminin was partially inhibited (at most a 50% reduc- 
tion in stimulated motility), and chemotaxis to fibronectin 
was unaffected. In contrast to the inhibition of chemotaxis, 
haptotaxis to all three ECM components was completely in- 
sensitive to inhibition by PT. CT and 8-Br-cAMP (10/zg/ml 
and 0.5 mM, respectively) did not significantly inhibit che- 
motactic or haptotactic motility. Pretreatment of the cells 
with 50-500 #g/ml of synthetic peptides containing the fi- 
bronectin cell-recognition sequence GRGDS resulted in a 
concentration-dependent inhibition of fibronectin-mediated 
chemotaxis and haptotaxis (to 20-30% of control motility); 
the negative control peptide GRGES had only a  minimal 
effect. Neither of  these peptides significantly inhibited motil- 
ity to laminin or type IV collagen. The protein synthesis in- 
hibitor, cycloheximide, caused a nonspecific 5-30% inhibi- 
tion of both the chemotactic and haptotactic responses to all 
three ECM proteins.  However, as has been seen for other 
chemoattractants  (7),  cycloheximide failed to abolish  the 
significant motility response. 
As stated previously, A2058 cells migrated in a concentra- 
tion-dependent manner to gradients of soluble laminin, fibro- 
nectin,  and type IV collagen.  The concentration-response 
curves of laminin- and fibronectin-stimulated motility were 
bimodal with a rather narrow range of concentrations, which 
elicited a maximal response. This type of curve has been ob- 
served previously in the motility response of a Schwann cell 
tumor line to laminin (27), and of polymorphonuclear leuko- 
cytes to certain chemotactic factors. The decline in migra- 
tory response to higher than optimal concentrations of at- 
tractant may represent down regulation of the chemotactic 
factor receptors (cellular deactivation) (45) or reduction of 
the gradient, which is necessary for the stimulation of motil- 
ity due to more rapid diffusion at high concentrations of at- 
tractant (27). Checkerboard analyses demonstrated that lam- 
inin  and  fibronectin stimulated  predominantly directional 
motility responses in A2058 cells, in agreement with previ- 
ous results with murine melanoma cells (26). l_aminin also 
stimulated random migration,  as has been reported previ- 
ously with a series of laminin-deficient variant cell lines iso- 
lated from a heterogeneous murine tumor population (39). 
Type IV collagen stimulated both significant random and di- 
rectional motility, although directional motility was  more 
pronounced. Therefore, in the presence of a fluid phase con- 
centration gradient, all three ECM proteins tested have the 
ability to attract tumor cells. Laminin and type IV collagen 
also stimulate intrinsic motility when present in more uni- 
form concentrations around the cells. 
As with the chemotactic responses, haptotaxis of cells to 
step-density gradients of the three ECM proteins also in- 
creased as higher concentrations of protein were used to coat 
the filters. When filters were coated with similar concentra- 
tions of BSA, a nonmatrix protein, the level of migration ob- 
served was no higher than that seen over filters with no pro- 
tein coating at all (DPBS alone). This indicates that the cells 
were recognizing and responding to the ECM proteins in a 
specific manner, and not simply migrating nonspecifically 
over any protein which would bind to cell surfaces. When 
comparing the concentration-response curves for haptotaxis 
and chemotaxis, some differences between the two types of 
motility responses  become evident.  There appears  to be 
much less overlap of the three chemotaxis curves compared 
with the haptotaxis curves. The attractants in solution dif- 
fered substantially with respect to the magnitude of the peak 
response elicited; in addition, the concentrations of soluble 
attractants needed to elicit a peak response varied from 60 
nM for fibronectin to 370 nM for type IV collagen. In con- 
trast, the maximal haptotactic responses to the three proteins 
were very similar, as were the coating concentrations which 
elicited these responses. Haptotactic responses appeared to 
be almost "all-or-nothing" in that there were at most only one 
or two "intermediate" migratory responses before the peak 
response was reached. This peak migratory response over a 
broad range of protein concentrations could reflect satura- 
tion of potential binding sites on the polycadxmate mem- 
branes. These differences between the migratory patterns of 
haptotaxis and chemotaxis suggest differences in the mecha- 
nisms of activation. 
In neutrophils, chemotaxis is mediated by specific recep- 
tors coupled to G  proteins (12,  21,  52).  PT, which ADP- 
ribosylates and inactivates certain G  proteins (11, 31),  has 
been  shown  to  inhibit  a  number  of motility  responses. 
Among these are the chemotactic responses of polymorpho- 
nuclear leukocytes to FMLP (12). Other studies have shown 
that pretreatment of T-cell hybridoma cells and lymphosai'- 
coma cells  with  PT  significantly reduces their ability  to 
infiltrate hepatocyte monolayer cultures (36).  In addition, 
Stracke et al.  (42)  demonstrated that the chemotactic re- 
sponse of the A2058 cells to their AMF was abolished when 
the cells were pretreated with >10 ng/ml of PT. Inthese same 
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insensitive to the effects of PT (43).  In one cell type, then, 
two different ligands can  stimulate motility through bio- 
chemical pathways that are distinguishable by PT sensitivity. 
These results suggest that motility responses of the A2058 
cells to laminin, fibronectin, and type IV collagen could be 
distinguishable by PT  sensitivity. The  second messenger 
pathways that are activated upon binding of a matrix protein 
to its receptor are largely unknown. An inhibitory effect of 
PT on tumor cell motility induced by any of the ECM pro- 
teins would implicate the involvement of  a second messenger 
pathway regulated by a G protein. In fact, the chemotactic 
responses of  the cells to the three matrix proteins have a dis- 
tinctly different  profile of inhibition by PT, ranging from lack 
of inhibition (chemotaxis to fibronectin) to complete sensi- 
tivity over a broad range of concentrations (chemotaxis to 
type IV collagen). Chemotaxis to laminin was intermediate 
in sensitivity, with, at most, a 50-60%  reduction in stimu- 
lated motility. These results strongly suggest that, at least for 
chemotaxis, the three matrix proteins are  acting through 
specific and distinct receptors on the cell surface. More sur- 
prising was the fact that migration in response to a single at- 
tractant (i.e., type IV collagen) was sensitive to inhibition by 
PT when the attractant was in the fluid phase, but not when 
the same attractant was substratum bound. It therefore ap- 
pears that type IV collagen, and possibly laminin, can stimu- 
late migration through biochemical pathways activated by 
two distinct signal transduction mechanisms, depending on 
whether the proteins are presented to the cells in solution or 
in a solid phase. 
Because PT could cause net accumulation of cAMP in the 
cells, we wanted to rule out the possibility that elevations of 
cAMP levels were responsible for the inhibition of motility. 
We found that CT, which is known to ADP-ribosylate the 
stimulatory G protein (GO in an active configuration, had 
neither an inhibitory nor a stimulatory effect on chemotactic 
or haptotactic motility to any of the attractants. Similarly, 
the cAMP analogue, 8-Br-cAMP,  which has been shown to 
enter intact cells (8, 22), neither stimulated nor inhibited the 
chemotactic or haptotactic motility response to any of the 
tested ECM proteins. These data agree with previous results 
(42)  demonstrating that G.~ and cAMP are not in the bio- 
chemical pathway that initiates stimulated motility in these 
cells. 
There are two possible explanations as to how soluble and 
insoluble laminin and type IV collagen stimulate tumor cell 
migration through distinct signal transduction pathways. One 
possibility is that chemotaxis and haptotaxis are mediated 
through only one receptor, and that there is a bifurcation at 
the level of the transducer for the soluble and insoluble at- 
tractant. Several recent studies have reported that activation 
of a single receptor can result in split signals (3, 5). In this 
model, the soluble attractant would activate a PT-sensitive 
G  protein-transduced biochemical pathway generating the 
motility response; the insoluble substratum-bound attractant 
would activate the motility response through a different trans- 
duction pathway. A more likely explanation for our data is 
that chemotaxis and haptotaxis to the same ECM protein 
could be mediated by different cell surface receptors, which 
recognize different structural domains of the proteins. In this 
model,  the  receptor(s)  mediating  chemotactic  migration 
would be coupled to PT-sensitive G proteins, whereas the re- 
ceptor(s) mediating haptotactic migration would not. Sev- 
eral recent reports have indicated that the same cellular re- 
sponse can be activated by different agonists acting through 
separate receptors which are distinct in their mechanisms of 
signal transduction (4,  15).  The possibility of separate re- 
ceptors-for ehemotaxis and haptotaxis to the same ECM gly- 
coprotein was raised by the recent work of Taraboletti et al. 
(47) with thrombospondin. Like other ECM glycoproteins, 
thrombospondin contains multiple domains through which it 
mediates cell adhesion and spreading. Through the use of 
mAbs and protease-derived fragments, it was demonstrated 
that haptotaxis and chemotaxis of A2058 cells to thrombo- 
spondin were each mediated by separate structural domains 
on the molecule. Because the domains of thrombospondin 
mediating chemotaxis and haptotaxis were located at oppo- 
site ends of the molecule, the implication was that separate 
receptors on the cell surface recognized each domain. 
Laminin, type IV collagen, and fibronectin each contain 
multiple domains which play roles in cellular adhesion and 
spreading. For laminin, the specific domains which promote 
cellular motility are undefined. For type IV collagen, the tri- 
ple helical domain and perhaps the globular NC! carboxy- 
terminal domain are involved in cell migration (14). The NCI 
domain has been shown to promote significant motility only 
when it is precoated onto the distal surface of polycarbonate 
membranes (haptotaxis) and not when it is in solution. For 
fibronectin, a 75-kD tryptic fragment containing the RGDS 
sequence has been shown to induce motility (29). Our data 
indicate that, for laminin and type IV collagen, more than 
one molecular domain is likely to play a role in cellular mi- 
gration. Which domains are predominantly involved appears 
to depend on the mode in which the ECM molecule is pre- 
sented to the cells. The data also confirm that the RGD- 
containing region of  fibronectin is important for both chemo- 
tactic and haptotactic migration by A2058 melanoma cells. 
As multidomain proteins, the ECM components appear to 
interact with the cells through multiple cell surface recep- 
tors. Each of the three molecules has been reported to bind 
to integrin-type receptors (9, 18, 20, 37, 41). The specific do- 
mains of laminin and type IV collagen that bind to these inte- 
grins are not yet defined but are thought to be distinct from 
RGD sequences present in the molecules. Our data indicate 
that the peptide GRGDS has little effect on either haptotactic 
or chemotactic migration to laminin and type IV collagen. 
Whether the integrin receptors play a role in laminin or type 
IV collagen-induced motility is still uncertain. In contrast, 
both types of migration to fibronectin were strongly inhibited 
by pretreatment of the cells with GRGDS but not the control 
peptide,  GRGES.  Furthermore,  this  inhibitory  effect on 
fibronectin-induced motility was additive to the milder inhi- 
bition caused by the protein synthesis inhibitor, cyclohex- 
imide. These data indicate that the RGD-directed site may 
have a long half-life and therefore may not be affected by the 
relatively brief treatment with cycloheximide. Consequently, 
the  interaction of the  cells  with  the  RGDS  sequence  of 
fibronectin, presumed to be through the integrin receptor 
(37),  appears necessary to promote both chemotactic and 
haptotactic motility, although it might not be sufficient. Ad- 
hesion at the RGDS site may be necessary to provide traction 
(in haptotaxis) and/or to place the active site on the ligand 
in proximity to the relevant receptor(s), leading to locomo- 
tion (in chemotaxis). 
The Journal of Cell Biology,  Volume 110, 1990  1436 In conclusion,  receptor-mediated  migration of a human 
melanoma cell line to the ECM components laminin, type 
IV collagen, and fibronectin is activated through distinct sig- 
nal transduction mechanisms. For laminin and type IV colla- 
gen, haptotactic and chemotactic migration to the same mol- 
ecule  is  distinguished  by  sensitivity  to  PT.  These  results 
suggest that separate domains of the proteins, acting through 
separate cell surface receptors, are responsible for mediating 
each type of motility response. In solution, laminin or type 
IV collagen may be able to expose an active chemotaxis-pro- 
moting domain to the cells that is not accessible to the cells 
when the same protein is insolubilized. Conversely, insolu- 
bilized  laminin  or  type  IV  collagen  may  present  certain 
haptotaxis-promoting domains. In any case, our results illus- 
trate the complexity of tumor cell migration in response to 
ECM proteins. Tumor cells interact with the ECM at multi- 
ple stages during invasion and metastasis (23, 24). Larninin 
and type IV collagen are normally present as predominantly 
insoluble structures  in host basement membranes.  During 
the initial stages of extravasation,  the ability of these proteins 
to stimulate haptotactic migration of the tumor cells may be 
more significant. Insoluble fibronectin in the interstitial stroma 
would then be accessible to the cells, further directing their 
migration. Tumor cells have been demonstrated to produce 
certain proteolytic enzymes during invasion, including type 
IV collagenase (23), cathepsin B (40), and urokinase (a plas- 
minogen activator)  (30).  Conceivably,  then,  metastasizing 
tumor cells could encounter localized pools of matrix pro- 
teins in a soluble, partially degraded form that could provide 
additional stimulation of both random and directional move- 
ment of tumor cells. Other soluble chemotactic factors could 
play a role in the final "homing" of tumor cells to specific 
target  organs.  These factors,  together with the ubiquitous 
ECM components, provide aggressive tumor cells with mul- 
tiple mechanisms allowing migration to distant  sites. 
The studies were partially  supported by the Susan B. Koman Foundation. 
References 
1. Basara, M.  L., J. B. McCarthy,  D. W.  Barnes, and L. T.  Furcht.  1985. 
Stimulation of haptotaxis and migration of tumor cells by serum spread- 
ing factor.  Cancer Res.  45:2487-2494. 
2. Bryant, G., C. N. Rao, M. Brentani, W. Martins, J. D. Lopes, S. E. Mar- 
tin, L. A. Liotta, and E. Schiffmann. 1987. A role for the laminin recep- 
tor in leukocyte chemotaxis.  J.  Leukocyte Biol. 41:220-227. 
3. Burch,  R.  M.,  A.  Luini,  and J.  Axelrod.  1986. Phospholipase A2 and 
phospholipase C are activated  by distinct GTP-binding  proteins  in re- 
sponse to ot-I adrenergic stimulation in FRTL5 thyroid cells. Proc. Natl. 
Acad.  Sci. USA. 83:7201-7205. 
4.  Chambard,  J. C., S. Paris,  G. L'Allemain,  and J. Pouyssegur.  1987. Two 
growth factor signaling pathways in fibroblasts distinguished by pertussis 
toxin. Nature  (Lond.).  326:800-803. 
5. Church,  J.  G.,  and  R.  N.  Buick. 1988. G-protein-mediated  epidermal 
growth factor signal transduction in a human breast cancer cell line. J+ 
Biol.  Chem. 263:4242-4246. 
6.  Edgar, D., R. Timpl, and H. Thoenen.  1984. The heparin-binding domain 
of laminin is responsible for its effects on neurite outgrowth and neuronal 
survival.  EMBO  (Eur+ Mol. Biol. Organ.)J.  3:1463-1468. 
7. Gallin, J. I., D. G. Wright,  and E.  Schiffmann.  1978. Role of secretory 
events  in  modulating  human  neutrophil  chemotaxis.  J.  Clin. Invest. 
62:1364-1374. 
8. Gard,  D.  L., and E.  Lazarides.  1982. Analysis of desmin and vimentin 
phosphopeptides in cultured avian myogenic cells and their modulation 
by 8-bromoadenosine 3',5'-cyclic monophosphate. Proc. Natl. Acad. Sci. 
USA. 79:6912-6916. 
9. Gehlsen, K. R., L. Dillner, E. Engvall, and E. Ruoslahti. 1988. The human 
laminin receptor is a member of  the integrin family of  cell adhesion recep- 
tors.  Science (Wash. DC). 241:1228-1229. 
10. Gilman, A. G. 1984. G proteins and dual control of adenylate cyclase. Cell. 
36:577-579. 
I I. Gilman, A. G. 1987. G proteins: transducers of receptor-generated signals. 
Annu.  Rev. Biochem.  56:615-649. 
12. Goldman,  D. W.,  E-H. Chang,  L.  A.  Gifford,  E.  J.  Goetzl,  and H.  R. 
Bourne.  1985. Pertussis toxin inhibition of chemotactic  factor-induced 
calcium mobilization and function in human polymorphonuclear leuko- 
cytes. J.  Exp. Med. 162:145-156. 
13.  Harvath, L., W. Falk, and E. J. Leonard.  1980. Rapid quantitation of neutro- 
phil chemotaxis: use of a polyvinylpyrrolidone-free polycarbonate mem- 
brane in a multiwell assembly. J.  lmmunol.  Methods.  37:39-45. 
14.  Herbst,  T. J.,  J.  B.  McCarthy, E.  C.  Tsilibary, and  L.  T.  Furcht.  1988. 
Differential effects of laminin,  intact type IV collagen, and specific do- 
mains of type IV collagen on endothelial cell adhesion and migration. J. 
Cell Biol. 106:1365-1373. 
15.  Huang, C.-L., and H. E. Ires. 1989. Gnanosine 5'-O-(3-Thiotrisphosphate) 
potentiates  both  thrombin-  and  platelet-derived  growth factor-induced 
inositol phosphate release in permeabilized vascular smooth muscle cells. 
J.  BioL Chem. 264:4391-4397. 
16.  Hujanen,  E.  S.,  and V.  P.  Terranova.  1985. Migration of tumor cells  to 
organ-derived chemoattractants.  Cancer ICes. 45:3517-3521. 
17.  Hynes, R. O., and K. M. Yamada. 1982. Fibronectins: multi  functional mod- 
ular glyeoproteins. J.  Cell BioL 95:369-377. 
18.  Ignatius, M. J., and L. E Reichardt. 1988. Identification of a neuronal lami- 
nin receptor: an Mr 200K/120K integrin heterodimer that binds laminin 
in a divalent cation-dependent manner. Neuron.  1:713-725. 
19. Katada, T., and M. Ui.  1982. Direct modification of the membrane adeny- 
late cyclase system by islet-activating protein due to ADP-ribosylation of 
a membrane protein. Proc. Natl. /Wad. Sci. USA. 79:3129-3133. 
20. Kramer, R. H., and N. Marks.  1989. Identification of integrin collagen re- 
ceptors on human melanoma cells. J.  Biol. Chem. 264:4684-4688. 
21.  Lad, P. M., C. V. Olson, I. S. Grewal, and S. J. Scott.  1985. A pertussis 
toxin-sensitive  GTP-binding protein  in the human neutrophil  regulates 
multiple  receptors,  calcium  mobilization,  and lectin-induced capping. 
Proc. Natl. Acad.  Sci.  USA. 82:8643-8647. 
22.  Leitman, D. C., R. R. Fiscus, and F. Murad.  1986. Forskolin, phosphodi- 
esterase inhibitors, and cyclic AMP analogs inhibit proliferation of cul- 
tured bovine aortic endothelial cells. J.  Cell. Physiol.  127:237-243. 
23.  Liotta, L. A. 1986. Tumor invasion and metastases: role of  the extracellular 
matrix.  Cancer Res. 46:1-7. 
24. Liotta,  L. A., and M.  L. Stracke.  1988. Tumor invasion and metastases: 
biochemical mechanisms.  Chapter  10.  In  Breast Cancer:  Cellular  and 
Molecular Biology. M. E. Lippmann and R. B. Dickson, editors. Marti- 
nus Nijhoff Publishers,  Boston. 223-238. 
25.  Liotta, L. A., R. Mandler, G. Murano, D. A. Katz, R. K. Gordon, P. K. 
Chiang, and E. Schiffmann. 1986. Tumor cell autocrine motility factor. 
Proc. Natl. Acad.  Sci. USA. 83:3302-3306. 
26.  McCarthy, J. B., and L. T. Furcht.  1984. Laminin and fibronectin promote 
the haptotactic migration of BI6 mouse melanoma cells in vitro. J.  Cell 
Biol.  98:1474-1480. 
27.  McCarthy, J. B., S. L. Palm, and L. T. Furcht.  1983. Migration by hapto- 
taxis of a Scbwann cell tumor line to the basement membrane glycopro- 
tein laminin. J.  Cell Biol. 97:772-777. 
28.  McCarthy, J. B., M. L. Basara, S. L. Palm, D. F. Sas, and L. T. Furcht. 
1985. The role of cell adhesion proteins-laminin and fibronectin-in the 
movement  of malignant  and  metastatic cells.  Cancer Metastasis Rev. 
4:125-152. 
29.  McCarthy, J. B., S. T. Hagen, and L. T. Furcht.  1986. Human fibronectin 
contains distinct adhesion- and motility-promoting domains for metastatic 
melanoma cells. J.  Cell Biol. 102:179-188. 
30. Mignatti, P., E. Robbins, and D. B. Rifkin. 1986. Tumor invasion through 
the human amniotic membrane:  requirement  for a proteinase cascade. 
Cell. 47:487-498. 
31.  Moss, J., M. Vaughan, and E. L. Hewlett. 1985. In Pertussis Toxin. R. D. 
Sekura, J. Moss, and M. Vanghan, editors. Academic Press, New York. 
105-128. 
32. Orr, W., J. Varani, M. D. Gondek, P. A. Ward, and G. R. Mundy.  1979. 
Chemotactic responses of tumor cells to products of resorbing bone. Sci- 
ence  (Wash. DC). 203:176-179. 
33.  Pierschbacher,  M. D., and E. Ruoslahti.  1984. Cell attachment activity of 
fibronectin can be duplicated by small synthetic fragments of the mole- 
cule. Nature  (Load.).  309:30-33. 
34. Rogers,  S.  L.,  P.  C.  Letourneau,  S.  L.  Palm,  J.  McCarthy,  and L.  T. 
Furcht.  1983. Neurite extension by peripheral and central nervous system 
neurons m response to substratum-bound fibronectin and laminin. Dev. 
Biol.  98:212-220. 
35.  Romualdez, A. G., Jr., and P. A. Ward.  1975. A unique complement de- 
rived chemotactic factor for tumor cells.  Proc.  Natl. Acad. Sci. USA. 
72:4128-4132. 
36.  Roos, E., and I. V. Van de Pavert.  1987. Inhibition oflymphoma invasion 
and liver metastasis formation by pertussis toxin. Cancer Res. 47:5439- 
5444. 
37.  Ruoslahti,  E.  1988. Fibronectin  and its receptors.  Annu. Rev. Biochem. 
57:375-413. 
38. Ruoslahti,  E., and M.  D. Pierschbacher.  1987. New perspectives in cell 
Aznavoorian et al. Signal  Transduction of Chemotaxis vs.  Haptotaxis  1437 adhesion: RGD and integrins. Science  (Wash. DC). 238:491-4971 
39. Situ, R., E. C. Lee, J. P. McCoy, Jr., and J. Varani. 1984. Stimulation 
of murine tumor cell motility  by laminin. J.  Cell Sci. 70:167-176. 
40. Sloane, B. F., K. V. Honn, J. G. Sadler, W. A. Turner, J. J. Kimpson, 
and J. D. Taylor.  1982. Cathepsin B activity in BI6 melanoma cells: a 
possible marker for metastatic potential.  Cancer Res.  42:980-986. 
41. Sonnenberg, A., P. W. Modderman, and F. Hogervorst.  1988.  Laminin 
receptor on platelets  is the integrin VLA-6. Nature  (Lond.). 336:487- 
489. 
42. Stracke,  M. L., R. Guirguis, L. A. Liotta, and E. Schiffmann. 1987. Per- 
tussis  toxin inhibits stimulated motility independently of the adenylate cy- 
clase pathway in human melanoma cells. Biochem. Biophys. Res. Com- 
mun.  146:339-345. 
43. Stracke, M. L., E. C. Kohn, S. A. Aznavoorian, L. L. Wilson, D. Salo- 
mon, H.~. Krutzsch, L. A. Liotta, and E. Schiffmann. 1988. Insulin-like 
growth factors stimulate  chemotaxis in human melanoma cells. Biochem. 
Biophys. Res. Commun.  153:1076--1083. 
44. Strauli, P., and G. Haemmerli. 1984.  The role of cancer cell motility  in 
invasion. Cancer Metastasis Rev.  3:127-141. 
45. Sullivan, S. J., and S. H. Zigmond. 1980.  Chemotactic peptide receptor 
modulation in polymorphonuclear leukocytes. J. Cell Biol. 85:703-711. 
46. Sun, O., and L. Weiss. 1984. The development of a technique for the mor- 
phometric analysis of invasion in cancer. J.  Theor. Biol. 107:547-561. 
47. Taraboletti,  G., D. D. Roberts, and L. A. Liotta.  1987. Thrombospondin- 
induced tumor cell migration: haptotaxis and chemotaxis are mediated by 
different  molecular domains. J.  Cell Biol. 105:2409-2415. 
:48.  Terranova,  V. P., R. DiFlorio,  E. S. Hujanen, R. M. Lyall,  L. A. Liotta, 
U. Th0rgeirsson,  G. P. Siegal,  and E. Schiffmann. 1986.  Laminin pro- 
motes"  rabbit  neutrophil  motility  and attachment.  J. Clin. Invest. 77: 
1180-i 186: 
49. Thiery,  J. P.,  J. L. Duband, and G. C. Tucker. 1985. Cell  migration  in 
the vertebrate  embryo: role  of  cell  adhesion  and tissue  environment in 
pattern formation. Annu.  Rev.  Cell Biol.  1:91-113. 
50. Timpl, R., H. Rohde, P. G. Robey, S. 1. Rennard, J. M. Foidart, andG. R. 
Martin.  1979.  Laminin-a glycoprotein from basement membranes. 3.. 
Biol.  Chem. 254:9933-9937. 
5 I. Todaro, G. J., C. Fryling, and J. E. DeLarco. 1980. Transforming  g.rowth 
factors produced by certain human tumor cells: polypeptides  that interact 
with epidermal growth factor receptors.  Proc.  Natl. Acad. Sci. USA. 
77:5258-5262. 
52. Verghese, M. W., L. Charles, L. Jakoi, S. B. Dillon, and R. Snyderman. 
1987.  Role of a guanine nucleotide regulatory protein in the activation 
of phospholipase C  by  different  chemoattractants. J.  lmmunol.  138: 
4374--4380. 
53. yon der Mark, K., and U. Kuhl. 1985. Laminin and its receptor. Biochim. 
Biophys. Acta. 823:147-160. 
54. Wewer, U. M., G. Taraboletti, M. E. Sobel, R. Albrechtsen, and L. A. 
Liotta.  1987. Role of laminin receptor in tumor cell migration. Cancer 
Res. 47:5691-5698. 
55. Yamada, K. M. 1983. Cell surface interactions with extracellular materials. 
Annu.  Rev. Biochem.  52:761-799. 
The Journal of Cell Biology, Volume 110,  1990  1438 